Holen Sie sich die Stockscreener-App
0.9604
3.27%
0.0304
Elutia Inc Aktie (ELUT) Neueste Nachrichten
Elutia Inc (ELUT) Institutional Confidence - TradingKey
Elutia Inc (ELUT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Elutia Inc (ELUT) Cash Flow - TradingKey
Elutia Inc (ELUT) Balance Sheet - TradingKey
Elutia Inc (ELUT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Elutia Inc (ELUT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
ELUT|Elutia Inc|Price:0.930|Chg%:-0.003 - TradingKey
Elutia Inc (ELUT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Elutia, Inc. Revenue Breakdown – NASDAQ:ELUT - TradingView
Elutia, Inc. Revenue Breakdown – BOATS:ELUT - TradingView
Elutia Inc (ELUT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Elutia Inc (ELUT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Elutia Sells SimpliDerm Business for Up to $11M to Fund NXT-41x Launch in $1.5B Plastic Surgery Market 1 - Minichart
Elutia Divests SimpliDerm Assets to Refocus Strategy - TipRanks
Lake Street Reaffirms Their Buy Rating on Elutia (ELUT) - The Globe and Mail
Elutia Sheds Legacy Business to Chase $1.5 Billion Market Opportunity - Benzinga
Elutia Agrees to Sell SimpliDerm for Up to $11 Million - marketscreener.com
Elutia to sell SimpliDerm business for up to $11 million - Investing.com
Elutia (ELUT) Finalizes Sale of SimpliDerm Business for Up to $1 - GuruFocus
Cellution Biologics Inc. Signs Definitive Agreement to Acquire SimpliDerm® Human Hydrated Acellular Dermal Matrix Business from Elutia Inc., Expanding its Allograft Portfolio - The Manila Times
Cellution Biologics Inc. Signs Definitive Agreement to - GlobeNewswire
Elutia Signs Definitive Agreement to Sell SimpliDerm® in - GlobeNewswire
Elutia Inc. (ELUT) Holds Steady Near Support as Uptrend Faces ResistanceGrowth Stock Picks - dars.gov.et
Cellution Biologics Llc agreed to acquire SimpliDerm human acellular dermal matrix business of Elutia Inc. for $11 million. - marketscreener.com
Elutia Inc. (ELUT) Q1 2026 Earnings: EPS Misses Estimates Amid Strategic ProgressProfit Recovery Report - dars.gov.et
Elutia Inc. (ELUT) Bounces From Support, Tests Key Resistance at $1.01RVOL Breakout - dars.gov.et
Elutia (ELUT) Q1 2026 Earnings: EPS Miss Weighs on Sentiment Amid Ongoing RestructuringDividend Cut Risk - DonanımHaber
Elutia Inc.(NasdaqCM: ELUT) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Elutia Inc.(NasdaqCM: ELUT) added to Russell 3000E Growth Benchmark - marketscreener.com
Elutia Inc Class A Actuals & Estimates (NASDAQ:ELUT) - TradingView
Enterprise value to EBITDA forward of Elutia, Inc. – NASDAQ:ELUT - TradingView
Price to sales forward of Elutia, Inc. – NASDAQ:ELUT - TradingView
ELUT Forecast — Price Target — Prediction for 2027 - TradingView
Elutia Holds Near Key $1 Level After Marginal DeclineGolden Cross - dars.gov.et
Enterprise value to revenue forward of Elutia, Inc. – NASDAQ:ELUT - TradingView
Price to book forward of Elutia, Inc. – NASDAQ:ELUT - TradingView
Price to earnings forward of Elutia, Inc. – NASDAQ:ELUT - TradingView
Enterprise value to EBIT forward of Elutia, Inc. – NASDAQ:ELUT - TradingView
Form 4 Elutia Inc For: 22 June By Investing.com - Investing.com South Africa
Elutia (ELUT) CEO reports RSU vesting and tax withholding, boosting share holdings - Stock Titan
Elutia Inc (ELUT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Elutia Inc (ELUT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ELUT: Drug-eluting biologic for breast reconstruction targets high infection rates in a $1.5B market - TradingView
Elutia Q1 2026 Earnings: EPS Misses Estimates Amid Operational ChallengesBanking Earnings Report - newsline.com
ELUT Q1 2026 Earnings: EPS Misses Estimates Despite Positive Stock ReactionCost Structure Review - dars.gov.et
Elutia Inc. (NASDAQ: ELUT) Files 8-K with Updated Company Information and Key SEC Details – June 2026 - Minichart
Elutia shareholders approve board proposals at annual meeting - Investing.com
Elutia shareholders approve board proposals at annual meeting By Investing.com - Investing.com India
Elutia Shareholders Approve Amended Incentive Plan and Governance - TipRanks
Elutia (ELUT) investors approve equity plan amendment and annual say-on-pay - Stock Titan
Elutia Inc. (ELUT) Q1 2026 Earnings: EPS Misses Estimates as Company Navigates Early-Stage PipelineRevenue Warning Signal - newsline.com
Elutia (ELUT) grants director Kevin Rakin 159,590 stock options - Stock Titan
Elutia (NASDAQ: ELUT) director awarded 106K stock options as compensation - Stock Titan
Elutia (NASDAQ: ELUT) director receives 106,393 stock options at $0.96 strike - Stock Titan
Elutia (NASDAQ: ELUT) director Brigid Makes receives 106,393-share stock option grant - Stock Titan
ELUT Q1 2026 Earnings: EPS Misses Estimates, Stock Ticks UpNext Quarter Guidance - newsline.com
0.79%
4.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):